Skip to main content

Pergolide Pregnancy and Breastfeeding Warnings

Pergolide is also known as: Permax

Pergolide Pregnancy Warnings

Pergolide has been assigned to pregnancy category B by the FDA. Animal studies using high oral doses of pergolide have failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Pergolide should only be used during pregnancy when need has been clearly established.

See references

Pergolide Breastfeeding Warnings

There are no data on the excretion of pergolide into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Permax (pergolide)." Athena Neurosciences Inc (2001):

References for breastfeeding information

  1. "Product Information. Permax (pergolide)." Athena Neurosciences Inc (2001):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.